Kappa opioid receptor and dynorphin signaling in the central amygdala regulates alcohol intake. 2021

Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
Bowles Center for Alcohol Studies, Curriculum in Neuroscience, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Excessive alcohol drinking has been shown to modify brain circuitry to predispose individuals for future alcohol abuse. Previous studies have implicated the central nucleus of the amygdala (CeA) as an important site for mediating the somatic symptoms of withdrawal and for regulating alcohol intake. In addition, recent work has established a role for both the Kappa Opioid Receptor (KOR) and its endogenous ligand dynorphin in mediating these processes. However, it is unclear whether these effects are due to dynorphin or KOR arising from within the CeA itself or other input brain regions. To directly examine the role of preprodynorphin (PDYN) and KOR expression in CeA neurons, we performed region-specific conditional knockout of these genes and assessed the effects on the Drinking in the Dark (DID) and Intermittent Access (IA) paradigms. Conditional gene knockout resulted in sex-specific responses wherein PDYN knockout decreased alcohol drinking in both male and female mice, whereas KOR knockout decreased drinking in males only. We also found that neither PDYN nor KOR knockout protected against anxiety caused by alcohol drinking. Lastly, a history of alcohol drinking did not alter synaptic transmission in PDYN neurons in the CeA of either sex, but excitability of PDYN neurons was increased in male mice only. Taken together, our findings indicate that PDYN and KOR signaling in the CeA plays an important role in regulating excessive alcohol consumption and highlight the need for future studies to examine how this is mediated through downstream effector regions.

UI MeSH Term Description Entries
D008297 Male Males
D004399 Dynorphins A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters. Dynorphin,Dynorphin (1-17),Dynorphin A,Dynorphin A (1-17)
D005260 Female Females
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017473 Receptors, Opioid, kappa A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins. Opioid Receptors, kappa,Receptors, kappa,Receptors, kappa Opioid,kappa Receptors,kappa Opioid Receptor,kappa Receptor,Opioid Receptor, kappa,Receptor, kappa,Receptor, kappa Opioid,kappa Opioid Receptors
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D066274 Central Amygdaloid Nucleus A nucleus located in the caudal half of the amygdala. It is a primary region involved in controlling responses and receives many intrinsic GABAergic amygdaloid connections. Central Amygdala Nucleus,Central Amygdala,Central Nucleus of Amygdala,Central Nucleus of the Amygdala,Amygdala Central Nucleus,Amygdala Nucleus, Central,Amygdala, Central,Amygdalas, Central,Amygdaloid Nucleus, Central,Central Amygdalas,Nucleus, Central Amygdala,Nucleus, Central Amygdaloid

Related Publications

Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
May 2019, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
January 2021, eNeuro,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
January 2012, Frontiers in molecular neuroscience,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
January 2017, International review of neurobiology,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
June 2022, Biological psychiatry,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
September 2011, Biological psychiatry,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
February 2014, Neuropharmacology,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
June 2012, Alcohol (Fayetteville, N.Y.),
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
May 2018, Pain,
Daniel W Bloodgood, and J Andrew Hardaway, and Christina M Stanhope, and Dipanwita Pati, and Melanie M Pina, and Sofia Neira, and Shivani Desai, and Kristen M Boyt, and Richard D Palmiter, and Thomas L Kash
January 2000, DNA and cell biology,
Copied contents to your clipboard!